The global metabolism assays market is poised for robust growth, projected to reach US$ 3.1 Billion by 2034. Driven by the increasing prevalence of metabolic disorders like obesity, type 2 diabetes, and hypertension, the demand for these analytical tools is surging. Advancements in technology, particularly in NMR spectroscopy, are further fueling market expansion. This report delves into the market’s key drivers, regional insights, and leading players.
Results for: Metabolic Disorders
PGI Chandigarh has launched a new ‘Metabolic Clinic’ to provide integrated care to patients with chronic liver disease and metabolic risk factors such as diabetes and obesity. The clinic aims to offer one-stop management of these conditions, facilitating patient convenience and improving outcomes.